NCT03877731View on ClinicalTrials.gov

Mitral Valve in Hypertrophic Cardiomyopathy

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2006

Primary Completion Date

May 30, 2019

Study Completion Date

September 1, 2019

Conditions
Hypertrophic Obstructive Cardiomyopathy
Interventions
PROCEDURE

isolated septal myectomy

PROCEDURE

septal myectomy + edge-to-edge mitral valve repair

PROCEDURE

septal myectomy + posterior leaflet sliding plasty

PROCEDURE

septal myectomy + secondary chordae transection

Trial Locations (1)

634012

Cardiology research institute, National Research Medical Center of the Russian Academy of Sciences, Tomsk

All Listed Sponsors
lead

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER

NCT03877731 - Mitral Valve in Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter